Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

England invites all adults to get their COVID-19 vaccines

Thu, 17th Jun 2021 22:30

LONDON, June 17 (Reuters) - The health service in England
will open up COVID-19 vaccinations to everyone aged over 18 on
Friday, a big step towards the government's target of giving
every adult who wants a vaccine a first shot in the next month.

Prime Minister Boris Johnson on Monday pushed back the full
re-opening of England from lockdown until July 19 because of a
rise in cases, but also accelerated his vaccination plans,
pledging to give every adult a first dose by the same date.

"Offering all adults a jab less than 200 days after the
programme launched is one of our country’s greatest collective
achievements, saving over 14,000 lives so far," he said,
referring to Public Health England estimates of the impact of
the vaccine rollout.

Britain has given a first dose of a COVID-19 vaccine to more
than 42 million people, almost 80% of adults, while well over a
half have received both shots.

Health authorities in England, Wales, Scotland and Northern
Ireland each run their own vaccination campaigns. Wales and
Northern Ireland have already made vaccines available to any
adult, while Scotland is offering them to anyone over 30.

Pfizer, AstraZeneca and Moderna
vaccines are being rolled out across the United Kingdom,
although officials have said that people under 40 should be
offered an alternative to AstraZeneca's shot after it was linked
to rare blood clots.
(Reporting by Alistair Smout; editing by Michael Holden)

Related Shares

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.